Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study.

Krum H, Roecker EB, Mohacsi P, Rouleau JL, Tendera M, Coats AJ, Katus HA, Fowler MB, Packer M; Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group.

JAMA. 2003 Feb 12;289(6):712-8.

PMID:
12585949
2.

Carvedilol: a review of its use in chronic heart failure.

Keating GM, Jarvis B.

Drugs. 2003;63(16):1697-741. Review.

PMID:
12904089
3.

[The effectiveness of carvedilol in heart failure].

Kárpáti K, Brodszky V, Farsang C, Jermendy G, Vándorfi G, Zámolyi K, Gulácsi L.

Orv Hetil. 2006 Oct 8;147(40):1931-7. Review. Hungarian.

PMID:
17111685
4.

Tolerability of carvedilol in heart failure: clinical trials experience.

Krum H.

Am J Cardiol. 2004 May 6;93(9A):58B-63B. Review.

PMID:
15144940
5.

Carvedilol in the treatment of chronic heart failure.

Moe G.

Expert Opin Pharmacother. 2001 May;2(5):831-43. Review.

PMID:
11336626
6.

Carvedilol: use in chronic heart failure.

Doughty RN, White HD.

Expert Rev Cardiovasc Ther. 2007 Jan;5(1):21-31. Review.

PMID:
17187454
7.
8.

Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?

Fowler MB.

Eur Heart J. 1998 Dec;19 Suppl P:P17-25. Review.

PMID:
9886708
9.
10.

Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.

Kveiborg B, Major-Petersen A, Christiansen B, Torp-Pedersen C.

Vasc Health Risk Manag. 2007;3(1):31-7. Review.

11.

Pharmacodynamics of beta-blockers in heart failure: lessons from the carvedilol or metoprolol European trial.

Bauman JL, Talbert RL.

J Cardiovasc Pharmacol Ther. 2004 Jun;9(2):117-28. Review.

PMID:
15309248
12.

Pharmacological interventions for treating heart failure in patients with chagas cardiomyopathy.

Hidalgo R, Martí-Carvajal AJ, Kwong JS, Simancas-Racines D, Nicola S.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD009077. doi: 10.1002/14651858.CD009077.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;7:CD009077.

PMID:
23152267
13.

A risk-benefit assessment of carvedilol in the treatment of cardiovascular disorders.

Louis WJ, Krum H, Conway EL.

Drug Saf. 1994 Aug;11(2):86-93. Review.

PMID:
7946002
14.

Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction.

Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM.

JAMA. 2002 Jul 17;288(3):351-7. Review.

PMID:
12117400
15.

Beta-Blockers (Carvedilol) in Children with Systemic Ventricle Systolic Dysfunction - Systematic Review and Meta-Analysis.

Prijic S, Buchhorn R, Kosutic J, Vukomanovic V, Prijic A, Bjelakovic B, Zdravkovic M.

Rev Recent Clin Trials. 2014;9(2):68-75. Review.

PMID:
25198735
16.

The safety and tolerability of beta blockers in heart failure with reduced ejection fraction: is the current underutilization of this evidence-based therapy justified?

Kiel RG, Deedwania P.

Expert Opin Drug Saf. 2015;14(12):1855-63. doi: 10.1517/14740338.2015.1102225. Epub 2015 Oct 21. Review.

PMID:
26488593
17.

Carvedilol therapy after cocaine-induced myocardial infarction in patients with asthma.

Self T, Rogers ML, Mancell J, Soberman JE.

Am J Med Sci. 2011 Jul;342(1):56-61. doi: 10.1097/MAJ.0b013e3182087347. Review.

PMID:
21293248
18.

Effects of Beta-Blocker Withdrawal in Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis.

Prins KW, Neill JM, Tyler JO, Eckman PM, Duval S.

JACC Heart Fail. 2015 Aug;3(8):647-53. doi: 10.1016/j.jchf.2015.03.008. Review. Erratum in: JACC Heart Fail. 2015 Oct;3(10):847.

Items per page

Supplemental Content

Write to the Help Desk